
Common adverse reactions to lorlatinib include:
Swelling of extremities, hands and feet (edema).
Numbness or tingling in joints or extremities (peripheral neuropathy).
Weight gain.
Cognitive impairment (e.g., forgetfulness, confusion).
Fatigue.
Dyspnea.
Arthralgia.
Diarrhea.
Mood changes (e.g., depression, irritability).
Elevated blood lipid levels.
Cough.
In addition, lorlatinib may reduce fertility in males and impair normal reproductive function. If you have concerns about this, consult a healthcare professional.
The above is not an exhaustive list of all adverse reactions to lorlatinib. For more information, consult a healthcare professional or pharmacist.
Seek prompt medical advice if any adverse reaction occurs.
FDA,2021.03

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: